Showing results (1381-1390 of 1,772) with videos related to
Sort By:
Pageof 178
International Journal of Cancer|July 31, 2001
EBNA promoter usage in EBV-negative Burkitt lymphoma cell lines converted with a neomycin-resistant EBV strainA Maeda, C Kiss, F Chen, et al.Carcinogenesis|May 1, 1995
Design of a selectable reporter for the detection of mutations in mammalian simple repeat sequencesS M Kahn, M G Klein, W Jiang, et al.Tobacco Regulatory Science|November 10, 2015
Does Size Impact Attention and Recall of Graphic Health Warnings?Elizabeth G Klein, Abigail B Shoben, Sarah Krygowski, et al.Disaster Medicine and Public Health Preparedness|September 10, 2020
COVID-19 Models for Hospital Surge Capacity Planning: A Systematic ReviewMichael G Klein, Carolynn J Cheng, Evonne Lii, et al.Zootaxa|October 15, 2020
Phylogenetic relationships and biological features reveal that male Ostrinia furnacalis (Lepidoptera: Crambidae) in Northeast China can be categorized into postmedial line-based cladesXiao Han, Ri-Zhao Chen, Lan-Bing Li, et al.Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology|March 24, 2000
CIS--cloning of identical sequences between two complex genomesV Zabarovska, J Li, O Muravenko, et al.International Journal of Cancer|January 15, 1981
Chromosome 15 trisomy in spontaneous and carcinogen-induced murine lymphomas of B-cell originF Wiener, M Babonits, J Spira, et al.International Journal of Cancer|July 29, 1996
Natural resistance against tumors grafted into the brain in association with histocompatibility-class-I-antigen expressionT Yamasaki, Y Akiyama, M Fukuda, et al.Clinical Immunology and Immunopathology|June 1, 1989
Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition in infectious mononucleosis. II. Kinetics of sensitization against five EBV-encoded nuclear proteins and the latent membrane proteinR Szigeti, B Kallin, J Dillner, et al.International Journal of Clinical Pharmacology, Therapy, and Toxicology|February 1, 1984
Antiarrhythmic activity of esmolol (ASL-8052)--a novel ultra-short acting beta-adrenoreceptor blocking agentG Klein, A Wirtzfeld, E Alt, et al.Pageof 178